Intech Investment Management LLC Has $2.61 Million Holdings in Kenvue Inc. $KVUE

Intech Investment Management LLC lessened its holdings in Kenvue Inc. (NYSE:KVUE) by 38.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 151,071 shares of the company’s stock after selling 93,148 shares during the period. Intech Investment Management LLC’s holdings in Kenvue were worth $2,606,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of KVUE. Van ECK Associates Corp grew its position in Kenvue by 101.3% in the third quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after acquiring an additional 9,240,434 shares during the last quarter. American Century Companies Inc. grew its position in Kenvue by 22.4% in the third quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock valued at $601,267,000 after acquiring an additional 6,781,640 shares during the last quarter. Bessemer Group Inc. grew its position in Kenvue by 156.2% in the fourth quarter. Bessemer Group Inc. now owns 8,491,343 shares of the company’s stock valued at $146,475,000 after acquiring an additional 5,177,404 shares during the last quarter. Mondrian Investment Partners LTD bought a new position in Kenvue in the third quarter valued at about $79,269,000. Finally, Alliancebernstein L.P. grew its position in Kenvue by 115.9% in the second quarter. Alliancebernstein L.P. now owns 6,438,473 shares of the company’s stock valued at $134,757,000 after acquiring an additional 3,456,204 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.59% of the stock is owned by insiders.

Wall Street Analyst Weigh In

KVUE has been the topic of a number of recent analyst reports. Barclays decreased their target price on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. UBS Group reduced their price target on Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Argus upgraded Kenvue to a “hold” rating in a report on Friday, March 6th. Canaccord Genuity Group boosted their price target on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Finally, Zacks Research upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $19.33.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.32 on Wednesday. The business’s 50 day simple moving average is $17.40 and its 200 day simple moving average is $17.47. Kenvue Inc. has a one year low of $14.02 and a one year high of $23.63. The stock has a market capitalization of $33.25 billion, a PE ratio of 20.38, a PEG ratio of 1.32 and a beta of 0.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same period in the prior year, the business posted $0.24 earnings per share. The firm’s revenue was up 4.5% on a year-over-year basis. As a group, research analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s dividend payout ratio is presently 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.